Dianthus Therapeutics Statistics

Total Valuation

DNTH has a market cap or net worth of $655.57 million. The enterprise value is $374.76 million.

Market Cap	655.57M
Enterprise Value	374.76M

Important Dates

The next estimated earnings date is Thursday, March 20, 2025, after market close.

Earnings Date	Mar 20, 2025
Ex-Dividend Date	n/a

Share Statistics

DNTH has 29.60 million shares outstanding. The number of shares has increased by 1,617.89% in one year.

Current Share Class	29.60M
Shares Outstanding	29.60M
Shares Change (YoY)	+1,617.89%
Shares Change (QoQ)	+0.03%
Owned by Insiders (%)	0.22%
Owned by Institutions (%)	62.26%
Float	12.47M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	116.37
Forward PS	173.48
PB Ratio	1.93
P/TBV Ratio	1.94
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	69.84
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 18.30, with a Debt / Equity ratio of 0.00.

Current Ratio	18.30
Quick Ratio	18.07
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -25.99% and return on invested capital (ROIC) is -20.03%.

Return on Equity (ROE)	-25.99%
Return on Assets (ROA)	-18.96%
Return on Invested Capital (ROIC)	-20.03%
Return on Capital Employed (ROCE)	-24.49%
Revenue Per Employee	$101,245
Profits Per Employee	-$1.27M
Employee Count	53
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +13.82% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+13.82%
50-Day Moving Average	23.02
200-Day Moving Average	25.56
Relative Strength Index (RSI)	49.01
Average Volume (20 Days)	274,425

Short Selling Information

The latest short interest is 5.92 million, so 20.02% of the outstanding shares have been sold short.

Short Interest	5.92M
Short Previous Month	6.00M
Short % of Shares Out	20.02%
Short % of Float	47.50%
Short Ratio (days to cover)	22.54

Income Statement

In the last 12 months, DNTH had revenue of $5.37 million and -$67.09 million in losses. Loss per share was -$2.38.

Revenue	5.37M
Gross Profit	5.37M
Operating Income	-82.90M
Pretax Income	-56.68M
Net Income	-67.09M
EBITDA	-82.81M
EBIT	-82.90M
Loss Per Share	-$2.38

Full Income Statement

Balance Sheet

The company has $281.12 million in cash and $311,000 in debt, giving a net cash position of $280.81 million or $9.49 per share.

Cash & Cash Equivalents	281.12M
Total Debt	311,000
Net Cash	280.81M
Net Cash Per Share	$9.49
Equity (Book Value)	337.90M
Book Value Per Share	11.51
Working Capital	271.78M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$62.59 million and capital expenditures -$84,000, giving a free cash flow of -$62.67 million.

Operating Cash Flow	-62.59M
Capital Expenditures	-84,000
Free Cash Flow	-62.67M
FCF Per Share	-$2.12

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-1,544.99%
Pretax Margin	-1,250.32%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

DNTH does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1,617.89%
Shareholder Yield	-1,617.89%
Earnings Yield	-10.23%
FCF Yield	-9.56%

Analyst Forecast

The average price target for DNTH is $46.43, which is 109.62% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$46.43
Price Target Difference	109.62%
Analyst Consensus	Strong Buy
Analyst Count	9
Revenue Growth Forecast (5Y)	132.02%
EPS Growth Forecast (5Y)	-16.07%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

DNTH has an Altman Z-Score of 20.51 and a Piotroski F-Score of 2.

Altman Z-Score	20.51
Piotroski F-Score	2